SCHEMBL97724

SCHEMBL97724

[142Pr]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL29350294 1.00
SCHEMBL29535649 1.00
SCHEMBL2997438 1.00
Lithium Ion SCHEMBL278068 0.71
Lithium Ion SCHEMBL3894889 0.71 CYP3A4 (0.33)
Lithium Ion SCHEMBL2020200 0.71
Bromide SCHEMBL34701 0.71
Lithium Ion SCHEMBL28778 0.71
Fluoride Ion SCHEMBL2951767 0.71 CA4 (0.50)
Lithium Ion SCHEMBL20533709 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 584 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083866-A1 COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-03-26 US claimed
WO-2024243545-A1 COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-11-28 WO claimed
WO-2021127007-A1 ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE BLUEBIRD BIO, INC. (US) 2021-06-24 WO claimed
EP-3813878-A1 ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE Bluebird Bio, Inc. (US) 2021-05-05 EP claimed
US-10195297-B2 Iron garnet nanoparticles for cancer radiotherapy and chemotherapy THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-02-05 US claimed
US-20180055954-A1 IRON GARNET NANOPARTICLES FOR CANCER RADIOTHERAPY AND CHEMOTHERAPY UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH 2018-03-01 US claimed
EP-1899983-B1 DEVICE AND METHOD FOR PREPARING A SMALL QUANTITY OF A RADIOACTIVE SUBSTANCE COMPOUND ITM Isotopen Technologien München AG (DE) 2016-04-06 EP claimed
EP-2099776-B1 CHELATING AGENT UNIV MUENCHEN TECH (DE) 2015-10-07 EP claimed
US-20150202337-A1 IRON GARNET NANOPARTICLES FOR CANCER RADIOTHERAPY AND CHEMOTHERAPY UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH 2015-07-23 US claimed
CN-103097399-A Compositions and methods for biofilm removal UNIV SOUTHERN CALIFORNIA 2013-05-08 CN claimed
US-5525338-A Detection and therapy of lesions with biotin/avidin conjugates IMMUNOMEDICS, INC. (US) 1996-06-11 US claimed
EP-0700304-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN-METAL CHELATING PROTEIN CONJUGATES Immunomedics, Inc. (US) 1996-03-13 EP claimed
EP-0695194-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN POLYMER CONJUGATES Immunomedics, Inc. (US) 1996-02-07 EP claimed
US-5482698-A Detection and therapy of lesions with biotin/avidin polymer conjugates IMMUNOMEDICS, INC. (US) 1996-01-09 US claimed
EP-0656115-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN CONJUGATES Immunomedics, Inc. (US) 1995-06-07 EP claimed
EP-0637933-A1 METHOD AND KIT FOR IMAGING AND TREATING ORGANS AND TISSUES Immunomedics, Inc. (US) 1995-02-15 EP claimed
WO-1994026297-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN-METAL CHELATING PROTEIN CONJUGATES IMMUNOMEDICS, INC. (US) 1994-11-24 WO claimed
WO-1994023759-A1 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN POLYMER CONJUGATES IMMUNOMEDICS, INC. (US) 1994-10-27 WO claimed
WO-1994004702-A2 IMPROVED DETECTION AND THERAPY OF LESIONS WITH BIOTIN/AVIDIN CONJUGATES IMMUNOMEDICS, INC. (US) 1994-03-03 WO claimed
WO-1993019668-A1 METHOD AND KIT FOR IMAGING AND TREATING ORGANS AND TISSUES IMMUNOMEDICS, INC. (US) 1993-10-14 WO claimed